Cannabis Compliance & Remediation

The DOJ's April 23, 2026 final order placed state-licensed medical marijuana into Schedule III immediately. For processors, the implication is not primarily tax—it is a 60-day priority DEA registration window in which documentation posture becomes the gating compliance variable.

California is the world's largest cannabis market and one of its strictest regulators. Here's a complete breakdown of California's microbial testing thresholds, approved remediation pathways, documentation requirements, and what multi-state operators need to align when they cross the state line.

Cannabis Schedule III rescheduling is not finalized—but the direction of travel is clear. Here's what the regulatory shift means specifically for processors, which FDA frameworks are most likely to apply, and why building GMP-aligned process controls now is the competitive advantage.

Most cannabis operators account for failed batches as a testing cost. They aren't. Here's the fully-loaded financial model — and the ROI case for switching from reactive remediation to in-process contamination control.

A complete walkthrough of Oregon's Metrc remediation logging process—from failed result to passing retest—covering every step compliance officers must execute correctly.

Most cannabis operations calling themselves 'cGMP ready' cannot produce the deviation logs, CAPAs, or batch records that would survive an FDA audit. Here's what cGMP actually requires—and why the gap between marketing language and audit reality is closing fast.

Multi-state operators face a compliance architecture problem that single-state operators don't: every state's remediation rules differ enough that a single SOP can't satisfy them all naively. Here's the framework for building a unified remediation SOP that actually travels across jurisdictions.

Minnesota activated full microbial and mycotoxin testing requirements in October 2025. New York updated Aspergillus and pathogen limits in February 2025. Maine's LD 1847 is advancing. The national testing expansion is accelerating—here's what each mandate requires and what processors must do now.

A contaminated cannabis product reaching retail is not just a quality event — it is a legal, regulatory, and reputational crisis. Here's how cannabis recalls work at the state level, what liability exposure processors actually face, and what documentation separates operators who survive a recall investigation from those who don't.

The Viridis, Keystone, and MCR Labs scandals exposed a systemic problem: cannabis testing labs have committed sustained, documented fraud on mold, potency, and heavy metals. Here's what the compliance record shows and what it means for processors depending on a passing COA.

On January 8, 2024, the FDA elevated vaporized hydrogen peroxide to an Established Category A sterilization method—the same tier as steam autoclave, ethylene oxide, and gamma radiation. Most cannabis operators don't know this happened, and fewer understand what it means for compliance defensibility.

Oregon's testing rules contain a provision that allows processors to bypass certain upstream tests when sterilization is part of the workflow. Here's what it means financially.

A peer-reviewed McGill University study found gamma irradiation reduces CFU counts but leaves mycotoxigenic fungi and toxin residues in cannabis. Here's what that means for processors relying on irradiation to pass compliance testing.

A side-by-side analysis of the three most developed cannabis remediation frameworks in the U.S.—Oregon, California, and Colorado—covering approved methods, timelines, documentation requirements, and MSO strategy.

Oregon processors depend on OLCC-licensed, ORELAP-accredited labs—but accreditation alone isn't enough. Here's how to evaluate lab quality and protect your remediation eligibility.

Lab shopping, manipulated results, and unvalidated remediation claims are documented problems in the cannabis industry. Here's how to identify red flags and verify what legitimate looks like.

An OLCC compliance audit of your remediation records follows a predictable path. Here's exactly what inspectors review, where processors fall short, and how to build a defensible audit trail.

A comprehensive comparison of cannabis microbial testing requirements across major U.S. states—CFU thresholds, approved pathogens, remediation allowances, and what it means for multi-state operators.

Ozone technology excels at air sterilization and surface mold control, but its origins and mechanism make it poorly suited for mold inside cannabis flower. Here's how VHP compares to ozone on penetration, terpene preservation, and cannabis compliance.

Unlike microbial failures, mycotoxin and heavy metals failures in Oregon cannot be remediated—destruction is mandatory. Here's what causes them, how to prevent them, and where VHP fits in.

The cannabis industry treats contamination as a binary outcome: pass or fail. Pharmaceutical manufacturing solved this decades ago by making purification continuous, not reactive. Cannabis is beginning to follow. Here's why that shift matters — and why the operators who make it first will be better positioned for everything that comes next.

Microbial contamination is the leading cause of cannabis batch failures nationally. Here's why it happens, what the industry data shows, and how processors are recovering failed product.

Oregon now requires mandatory microbial, heavy metal, and mycotoxin testing for all cannabis batches—with strict remediation protocols for failures. Here's what every processor must understand.

USDA's hemp testing framework requires ISO 17025-accredited labs, post-decarboxylation THC measurement, and destruction protocols for non-compliant samples. Here's how VHP fits within federal compliance.

Ozone, UV, gamma irradiation, chemical sprays, foggers—cannabis processors have tried them all. Here's why vaporized hydrogen peroxide (VHP) outperforms every alternative on penetration, validation, and regulatory standing.